Stock·NYSE·Technology
HubSpot, Inc. (HUBS)
- Market cap
- $11.52B
- P/E
- 79.10
- Dividend yield
- 0.00%
- Street target
- $250.00median of 35 analysts
- 52-week range
- $169.63 $497.96
The short version
Where HUBS stands today, in four lines, and what CleaRank Financial AI makes of it.
HUBS at a glance
HubSpot, Inc. (HUBS): Hold, 55/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($229.29 and $237.98).
- Earnings HUBS beat estimates in 6 of its last 6 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $68.9M and bought $2.8M over the last 18 months.
- Valuation P/E of 79.1 against 35.1 for the Technology sector: a premium to peers (+125%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates HubSpot, Inc. (HUBS) Hold with a model score of 55/100.
The earnings record is the biggest contributor to that score, having beaten estimates in 6 of its last 6 reports, with the latest beat at 7.95% above the estimate. Valuation is the largest drag: a P/E of 79.10, which is 125.4% above the sector median, marks a premium to peers. On trend, the stock is 0.72% above its 50-day average of $229.29 but 2.96% below its 200-day average of $237.98, so the trend reads as mixed. The price fell 46.63% over the past year.
Only on CleaRank
Figures we compute ourselves from HUBS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $230.94 is 0.7% above the 50-day simple moving average of $229.29.Price above its 200-day average ›
The price is 3.0% below the 200-day simple moving average of $237.98.50-day average above the 200-day ›
The 50-day average ($229.29) is 3.7% below the 200-day average ($237.98), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 19% of its 52-week range, between $169.63 and $497.96.
HUBS share price
Pick a period: each tab shows how far HUBS has moved over it, to the last close.
Today's trading
Where HUBS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 79.10 is 125.4% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 3.27 is 57.0% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $146.9M on revenue of $3.4B, a net margin of 4.3%.Beat estimates in most recent reports ›
HUBS beat the EPS estimate in 6 of its last 6 reports.
Key statistics
The headline figures for HUBS.
As of October 17, 2026, HUBS trades at $230.94, with a market value of $11.52B and a P/E ratio of 79.10.
What the numbers say
CleaRank Financial AI's reading of HUBS's valuation, growth and risks.
HubSpot, Inc. (HUBS) carries a P/E of 79.10, which is 125.4% above the 35.1 median for Technology stocks, a premium to peers by that measure. Its price-to-sales ratio of 3.27 is 57.0% below the sector median of 7.6. To put the size in context, the market capitalisation is $11.5B and trailing earnings are $2.86 a share.
Growth trails the sector: revenue grew 19.80% in the latest year, against a sector median of 24.2%. Profitability shows a net margin of 4.26% and an operating margin of 4.87%, with a return on equity of 7.89%, below the sector median of 13.4%. Rounding out the fundamentals, HUBS reports debt-to-equity of 0.14.
HUBS's latest earnings report came out on August 5, 2026, with EPS of $3.26. The figure beat the analysts' estimate by 7.95%, yet the share price dropped 19.10% in the first session after the release.
Across its last 6 reports, HUBS has topped the EPS estimate every time, yet that has not reliably lifted the shares: the stock dropped in the first session after 4 of those beats. Among the earlier reports, the November 5, 2025 release stands out. It beat the estimate by 2.70%, and the stock then fell 15.01%.
HUBS's average daily move is 3.88%. The P/E of 79.10, 125.4% above the sector median, puts HUBS at a premium to peers, so weaker results would meet a higher bar. The price is 53.62% below its 52-week high of $497.96. Insiders sold $68.9M over the last 18 months and bought $2.8M, though sales of this kind are often planned in advance and say less than purchases would.
HUBS against the Technology sector
How HUBS compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: HUBS trades at a significant premium to sector peers (+125%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, HUBS has lost 63.5% against a gain of 71.7% for XLK.
Performance against XLK
HUBS and the Technology sector fund over the same days.
Revenue and earnings
How much HUBS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 19.2% in FY2025 to $3.1B, from $2.6B a year earlier.
Profit margin: The net margin was 1.5% in FY2025, up from 0.2% the year before.
Profitable: HUBS earned $45.9M in FY2025.
Earnings reality check
Did HUBS beat what analysts expected, and how did the stock react?
Earnings record: HUBS beat the analyst estimate in 6 of the last 6 quarters.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 5, 2026after close | $3.02 | $3.26 | +7.95% | -19.10% | -16.02% |
| Feb 11, 2026after close | $2.99 | $3.09 | +3.34% | +9.37% | +14.35% |
| Nov 5, 2025after close | $2.59 | $2.66 | +2.70% | -15.01% | -15.06% |
| Aug 6, 2025after close | $2.12 | $2.19 | +3.30% | -6.24% | -11.14% |
| May 8, 2025after close | $1.76 | $1.78 | +1.14% | -8.68% | +0.56% |
| Feb 12, 2025after close | $2.20 | $2.32 | +5.45% | +4.36% | -4.77% |
As of October 17, 2026, HUBS has beaten the analyst EPS estimate in 6 of its last 6 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 5, 2026, came in 7.95% above the estimate and the stock moved -19.10% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 53.2, in neutral territory.RSI above 50 ›
An RSI of 53.2 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of HUBS
The score, the reasoning behind it, and what could move the price next.
HubSpot, Inc. (HUBS) shows a mixed trend. At $230.94, the stock is 0.72% above its 50-day average of $229.29, yet 2.96% below its 200-day average of $237.98. Trading 36.14% above its 52-week low of $169.63 and 53.62% below its 52-week high of $497.96, the price sits near the bottom of that range. Because the 50-day average is 3.65% below the 200-day, the recovery has yet to lift the stock above its longer-run averages.
Short-term and long-term signals disagree. Over the past month the price slipped 2.33%, yet over the past three months it climbed 2.98%, and over the past year it dropped 46.63%. The 14-day RSI sits at 53.2, which is neutral territory, while the MACD line is positive.
Earnings beat ›
The August 5, 2026 report beat the EPS estimate by 7.95%, and the share price fell 19.10% in the first session after it.
Source: Earnings report, August 5, 2026
Analyst downgrade ›
Barclays downgraded it to Equal-Weight from Overweight on October 12, 2026.
Source: Analyst action, Barclays, October 12, 2026Analyst downgrade ›
JP Morgan downgraded it to Neutral from Overweight on October 8, 2026.
Source: Analyst action, JP Morgan, October 8, 2026
- Keep an eye on the two closest levels: the 200-day SMA at $237.98 sits above the price, and the 50-day SMA at $229.29 sits below it.
- The 14-day RSI is 53.2, which is neutral, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- HUBS beat estimates in 6 of its last 6 reports, but after the August 5, 2026 report the share price dropped 19.10% in the first session.
HUBS has a mixed trend. Its price is above the 50-day average of $229.29 but under the 200-day average of $237.98. Closing above the 200-day would bring both signals to the upside, while closing below the 50-day would send both lower. The nearest levels are the 50-day SMA at $229.29 beneath the price and the 200-day SMA at $237.98 above it.
Technical indicators
Momentum and trend for HUBS, from its daily closes.
As of October 17, 2026, with HUBS at $230.94, its 14-day RSI is 53.2 (neutral territory), its 50-day simple moving average is $229.29 and its 200-day is $237.98.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What HUBS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, HUBS's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.25 with Nasdaq 100 (QQQ), +0.16 with Bitcoin (BTC) and -0.08 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
13 of 35 analysts rate it a buy or strong buy, 21 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $250.00 is 8.3% above the price.More buy ratings than three months ago ›
13 of 35 rate it a buy now, against 24 of 35 three months ago.
HUBS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Barclays | Downgrade | Equal-Weight |
| Oct 8, 2026 | JP Morgan | Downgrade | Neutral |
| Oct 7, 2026 | Cantor Fitzgerald | Reiterates | Neutral |
| Oct 6, 2026 | Needham | Reiterates | Buy |
| Oct 5, 2026 | Raymond James | Downgrade | Market Perform |
| Sep 21, 2026 | BMO Capital | Maintains | Market Perform |
As of October 17, 2026, 35 Wall Street analysts cover HUBS: 13 rate it a buy or strong buy, 21 a hold and 1 a sell or strong sell. Their 12-month price targets range from $190.00 to $320.00, with a median of $250.00, 8.3% above the price of $230.94.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
HUBS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
HUBS moves about 3.9% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much HUBS tends to move, against the market and on its own.
The long record
HUBS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 3.88% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 80.0%, from November 2021 to June 2026; the price is still 72.9% below that peak.Most 1-year holds ended higher ›
68% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $44,843, against $42,055 in the S&P 500 (SPY).
HUBS Drawdowns & Recovery
As of October 17, 2026, HUBS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -80.0% (November 2021 to June 2026); it is still 72.9% below that peak, and 68% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into HUBS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: HUBS beat the S&P 500 over this period: $44,843 against $42,055.
A $10,000 investment in HUBS in October 2016 would be worth about $44,843 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to HUBS, and which have not.
Strongest month, August: an average of +6.61%, up in 8 of 10 years.
Weakest month, September: an average of -4.71%, up in 4 of 10 years.
This month, October: has averaged +1.41%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, HUBS's strongest calendar month has been August (average +6.61%, up in 8 of 10 years) and its weakest September (average -4.71%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in HUBS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in HUBS today could grow to about $24,806 by 2036 in the base case, with a 90th-percentile outcome near $188,196 and a 10th-percentile outcome around $3,270. Projections are statistical simulations, not guarantees.
HUBS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $332 for HUBS by 2030 in the base case, from $231 today (1.4x over 4 years). The 10th-percentile path ends near $92.20. These are outcomes of a Monte Carlo simulation run on HUBS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $133 | $253 | $480 | |
| 2028 | $112 | $277 | $685 | |
| 2029 | $99.96 | $303 | $920 | |
| 2030 | $92.20 | $332 | $1,197 | |
| 2031 | $86.79 | $364 | $1,524 |
Method: a lognormal simulation of HUBS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. HUBS is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
HUBS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $2.8M on the open market and sold $68.9M.
As of October 17, 2026, HUBS insiders reported 32 open-market sales worth $68.9M and 4 open-market purchases worth $2.8M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $2.1M |
| Aug 18, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $1.9M |
| Aug 10, 2026 | Gerald Dischler
Director
|
Buy | 925 | $199.7K |
| Aug 5, 2026 | Gerald Dischler
Director
|
Grant | 1.0K | - |
| Aug 4, 2026 | Erika Ashley Fisher
Officer
|
Sell | 702 | $165.1K |
| Jul 21, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $1.9M |
| Jun 16, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $1.6M |
| Jun 16, 2026 | Andrew J Anagnost
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Michael J Berry
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Brian P Halligan
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Claire D'Oyly-Hughes Johnson
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Lorrie M Norrington
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Clara Shih
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Jay Simons
Director
|
Grant | 1.2K | - |
| Jun 16, 2026 | Jill A Ward
Director
|
Grant | 1.2K | - |
| May 19, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $1.9M |
| May 12, 2026 | Yamini Rangan
Chief Executive Officer
|
Buy | 2.8K | $522.1K |
| May 12, 2026 | Dharmesh P Shah
Chief Technology Officer
|
Buy | 10.0K | $1.8M |
| May 11, 2026 | Lorrie M Norrington
Director
|
Buy | 1.3K | $250.0K |
| May 4, 2026 | Erika Ashley Fisher
Officer
|
Sell | 915 | $216.5K |
| Apr 21, 2026 | Brian P Halligan
Director
|
Sell | 8.3K | $1.9M |
| Apr 1, 2026 | Michael J Berry
Director
|
Grant | 170 | - |
| Mar 17, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $2.2M |
| Mar 10, 2026 | Brian P Halligan
Director
|
Grant | 102.0K | - |
| Mar 2, 2026 | Kathryn Bueker
Chief Financial Officer
|
Grant | 16.7K | - |
| Mar 2, 2026 | Yamini Rangan
Chief Executive Officer
|
Grant | 37.9K | - |
| Mar 2, 2026 | Dharmesh P Shah
Chief Technology Officer
|
Grant | 8.7K | - |
| Feb 17, 2026 | Brian P Halligan
Director
|
Sell | 8.3K | $2.1M |
| Feb 12, 2026 | Kathryn Bueker
Chief Financial Officer
|
Grant | 5.9K | - |
| Feb 12, 2026 | Brian P Halligan
Director
|
Grant | 2.3K | - |
| Feb 12, 2026 | Yamini Rangan
Chief Executive Officer
|
Grant | 13.2K | - |
| Feb 12, 2026 | Dharmesh P Shah
Chief Technology Officer
|
Grant | 3.3K | - |
| Feb 4, 2026 | Erika Fisher
Officer
|
Sell | 1.4K | $348.5K |
| Jan 20, 2026 | Brian P Halligan
Director
|
Sell | 8.5K | $2.6M |
| Dec 16, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $3.1M |
| Dec 12, 2025 | Dharmesh P Shah
Chief Technology Officer
|
Grant | 15.5K | - |
| Dec 12, 2025 | Dharmesh P Shah
Chief Technology Officer
|
Option | 20.0K | $811.4K |
| Nov 18, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $3.1M |
| Nov 3, 2025 | Brian P Halligan
Director
|
Sell | 235 | $115.9K |
| Nov 3, 2025 | Brian P Halligan
Director
|
Option | 235 | $115.3K |
| Nov 3, 2025 | Clara Shih
Director
|
Grant | 310 | - |
| Oct 21, 2025 | Brian P Halligan
Director
|
Sell | 8.3K | $3.7M |
| Oct 21, 2025 | Brian P Halligan
Director
|
Option | 263 | $100.8K |
| Oct 6, 2025 | Yamini Rangan
Chief Executive Officer
|
Sell | 2.4K | $1.2M |
| Oct 6, 2025 | Kathryn Bueker
Chief Financial Officer
|
Sell | 615 | $307.5K |
| Sep 16, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $4.3M |
| Sep 16, 2025 | Brian P Halligan
Director
|
Option | 8.4K | $3.6M |
| Sep 9, 2025 | Dharmesh P Shah
Chief Technology Officer
|
Sell | 22.0K | $11.0M |
| Sep 8, 2025 | Yamini Rangan
Chief Executive Officer
|
Sell | 477 | $238.5K |
| Sep 8, 2025 | Kathryn Bueker
Chief Financial Officer
|
Sell | 119 | $59.5K |
| Aug 19, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $3.8M |
| Aug 19, 2025 | Brian P Halligan
Director
|
Option | 8.5K | $1.8M |
| Jul 15, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $4.6M |
| Jul 15, 2025 | Brian P Halligan
Director
|
Option | 7.7K | $1.4M |
| Jul 2, 2025 | Yamini Rangan
Chief Executive Officer
|
Sell | 2.4K | $1.3M |
| Jul 2, 2025 | Kathryn Bueker
Chief Financial Officer
|
Sell | 615 | $339.4K |
| Jun 17, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $4.7M |
| Jun 17, 2025 | Brian P Halligan
Director
|
Option | 7.0K | $1.1M |
| Jun 4, 2025 | Andrew J Anagnost
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Nicholas V. Caldwell
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Ronald S Gill
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Claire D'Oyly-Hughes Johnson
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Lorrie M Norrington
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Jay Simons
Director
|
Grant | 400 | - |
| Jun 4, 2025 | Jill A Ward
Director
|
Grant | 400 | - |
| Jun 3, 2025 | Yamini Rangan
Chief Executive Officer
|
Sell | 613 | $364.7K |
| Jun 3, 2025 | Kathryn Bueker
Chief Financial Officer
|
Sell | 239 | $142.6K |
| May 20, 2025 | Brian P Halligan
Director
|
Sell | 8.5K | $5.5M |
| May 20, 2025 | Brian P Halligan
Director
|
Option | 8.5K | $1.2M |
| May 19, 2025 | Kathryn Bueker
Chief Financial Officer
|
Sell | 2.7K | $1.8M |
| Apr 24, 2025 | Yamini Rangan
Chief Executive Officer
|
Sell | 680 | $408.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.